These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 17261116)

  • 61. Quality of life in Polish patients with multiple sclerosis.
    Mitosek-Szewczyk K; Kułakowska A; Bartosik-Psujek H; Hożejowski R; Drozdowski W; Stelmasiak Z
    Adv Med Sci; 2014 Mar; 59(1):34-8. PubMed ID: 24797971
    [TBL] [Abstract][Full Text] [Related]  

  • 62. New insights into the burden and costs of multiple sclerosis in Europe: Results for Switzerland.
    Calabrese P; Kobelt G; Berg J; Capsa D; Eriksson J;
    Mult Scler; 2017 Aug; 23(2_suppl):192-203. PubMed ID: 28643596
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A longitudinal survey of self-assessed health trends in a community cohort of people with multiple sclerosis and their significant others.
    Solari A; Ferrari G; Radice D
    J Neurol Sci; 2006 Apr; 243(1-2):13-20. PubMed ID: 16380136
    [TBL] [Abstract][Full Text] [Related]  

  • 64. New insights into the burden and costs of multiple sclerosis in Europe: Results for the Netherlands.
    Uitdehaag B; Kobelt G; Berg J; Capsa D; Dalén J;
    Mult Scler; 2017 Aug; 23(2_suppl):117-129. PubMed ID: 28643595
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain.
    Casado V; Romero L; Gubieras L; Alonso L; Moral E; Martinez-Yelamos S; Martinez-Yelamos A; Carmona O; Arbizu T
    Mult Scler; 2007 Jul; 13(6):800-4. PubMed ID: 17613609
    [TBL] [Abstract][Full Text] [Related]  

  • 66. New insights into the burden and costs of multiple sclerosis in Europe: Results for France.
    Lebrun-Frenay C; Kobelt G; Berg J; Capsa D; Gannedahl M;
    Mult Scler; 2017 Aug; 23(2_suppl):65-77. PubMed ID: 28643588
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of Personal Resources in Patients Who Differently Estimate the Impact of Multiple Sclerosis.
    Wilski M; Tomczak M
    Ann Behav Med; 2017 Apr; 51(2):179-188. PubMed ID: 27679463
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Health-related quality of life in Iranian patients with multiple sclerosis: a cross-cultural study.
    Pakpour AH; Yekaninejad MS; Mohammadi NK; Molsted S; Zarei F; Patti F; Harrison A
    Neurol Neurochir Pol; 2009; 43(6):517-26. PubMed ID: 20054754
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.
    Roxburgh RH; Seaman SR; Masterman T; Hensiek AE; Sawcer SJ; Vukusic S; Achiti I; Confavreux C; Coustans M; le Page E; Edan G; McDonnell GV; Hawkins S; Trojano M; Liguori M; Cocco E; Marrosu MG; Tesser F; Leone MA; Weber A; Zipp F; Miterski B; Epplen JT; Oturai A; Sørensen PS; Celius EG; Lara NT; Montalban X; Villoslada P; Silva AM; Marta M; Leite I; Dubois B; Rubio J; Butzkueven H; Kilpatrick T; Mycko MP; Selmaj KW; Rio ME; Sá M; Salemi G; Savettieri G; Hillert J; Compston DA
    Neurology; 2005 Apr; 64(7):1144-51. PubMed ID: 15824338
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey.
    Brodszky V; Péntek M; Bálint PV; Géher P; Hajdu O; Hodinka L; Horváth G; Koó E; Polgár A; Seszták M; Szántó S; Ujfalussy I; Gulácsi L
    Scand J Rheumatol; 2010 Aug; 39(4):303-9. PubMed ID: 20166848
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multiple sclerosis in the UK: service use, costs, quality of life and disability.
    McCrone P; Heslin M; Knapp M; Bull P; Thompson A
    Pharmacoeconomics; 2008; 26(10):847-60. PubMed ID: 18793032
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New insights into the burden and costs of multiple sclerosis in Europe: Results for Italy.
    Battaglia M; Kobelt G; Ponzio M; Berg J; Capsa D; Dalén J;
    Mult Scler; 2017 Aug; 23(2_suppl):104-116. PubMed ID: 28643600
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.
    Rabadi MH; Vincent AS
    Disabil Rehabil; 2013; 35(22):1877-84. PubMed ID: 23600712
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis.
    Hawton A; Shearer J; Goodwin E; Green C
    Appl Health Econ Health Policy; 2013 Aug; 11(4):331-41. PubMed ID: 23637055
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Risk factors of Multiple sclerosis and their Relation with Disease Severity: A Cross-sectional Study from Iran.
    Abbasi M; Nabavi SM; Fereshtehnejad SM; Ansari I; Zerafatjou N; Shayegannejad V; Mohammadianinejad SE; Farhoudi M; Noorian A; Razazian N; Abedini M; Faraji F
    Arch Iran Med; 2016 Dec; 19(12):852-860. PubMed ID: 27998160
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Costs and quality of life in multiple sclerosis patients with spasticity.
    Svensson J; Borg S; Nilsson P
    Acta Neurol Scand; 2014 Jan; 129(1):13-20. PubMed ID: 23683163
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis.
    Goodwin E; Green C; Spencer A
    Value Health; 2015 Dec; 18(8):1025-36. PubMed ID: 26686787
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multiple sclerosis: relapses, resource use, and costs.
    Hawton AJ; Green C
    Eur J Health Econ; 2016 Sep; 17(7):875-84. PubMed ID: 26438399
    [TBL] [Abstract][Full Text] [Related]  

  • 79. New insights into the burden and costs of multiple sclerosis in Europe: Results for Denmark.
    Rasmussen PV; Kobelt G; Berg J; Capsa D; Gannedahl M;
    Mult Scler; 2017 Aug; 23(2_suppl):53-64. PubMed ID: 28643589
    [TBL] [Abstract][Full Text] [Related]  

  • 80. New insights into the burden and costs of multiple sclerosis in Europe: Results for Spain.
    Oreja-Guevara C; Kobelt G; Berg J; Capsa D; Eriksson J;
    Mult Scler; 2017 Aug; 23(2_suppl):166-178. PubMed ID: 28643597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.